BDSX · Biodesix Inc

$22.00 -0.22 (-0.99%)

Market Cap

$224.61M

10.11M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Scott Hutton	CEO	$643,404	—	$356,849	$524,437	$710,280	$3,500	$2,238,470
Kieran O'Kane	Other	$443,048	—	$108,206	$159,023	$293,489	$3,526	$1,007,292
Robin Harper Cowie	CFO	$443,366	—	$108,206	$159,023	$244,707	$6,699	$962,001

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Scott Hutton	CEO	$588,858	—	$419,144	$852,017	$223,604	$1,250	$2,084,873
Kieran O'Kane	Other	$401,554	—	$128,118	$233,451	$137,522	—	$900,645
Robin Harper Cowie	CFO	$405,881	—	$128,118	$224,690	$115,597	$1,250	$875,536

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Scott Hutton	CEO	$515,000	—	$1,442,001	$233,622	$98,058	$1,865	$2,290,546
Robin Harper Cowie	CFO	$355,000	—	$372,751	$81,319	$33,797	$1,500	$844,367
Kieran O'Kane	Other	$335,000	—	$234,499	$45,555	$57,407	$205	$672,666

Key facts CIK 1439725 CUSIP 09075X207 13F (30d) 3 filings 3 filers Visit website Investor relations